Chiroli, Silvia
25  results:
Search for persons X
?
4

Cost Effectiveness of the Third-Generation Tyrosine Kinase ..:

Hirt, Carsten ; Iannazzo, Sergio ; Chiroli, Silvia...
Applied Health Economics and Health Policy.  17 (2019)  4 - p. 555-567 , 2019
 
?
5

Number-Needed-To-Treat (NNT) and Cost of Responses Achieved..:

Levy, Moshe Y. ; McGarry, Lisa ; Iannazzo, Sergio..
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  - p. S310 , 2017
 
?
6

Ponatinib versus Bosutinib in 3rd-Line Chronic Phase - Chro..:

McGarry, Lisa ; Yang, Mo ; Chiroli, Silvia..
Clinical Lymphoma Myeloma and Leukemia.  16 (2016)  - p. S58-S59 , 2016
 
?
9

A Cost-Utility Analysis of Cinacalcet in Secondary Hyperpar..:

Iannazzo, Sergio ; Carsi, Michela ; Chiroli, Silvia
Applied Health Economics and Health Policy.  10 (2012)  2 - p. 127-138 , 2012
 
?
13

Gabapentin vs. Amitriptyline in Painful Diabetic Neuropathy:

Dallocchio, Carlo ; Buffa, Carlo ; Mazzarello, Paolo.
Journal of Pain and Symptom Management.  20 (2000)  4 - p. 280-285 , 2000
 
?
 
?
 
1-15